Altimmune (ALT) Change in Taxes (2016 - 2021)
Altimmune (ALT) reported Change in Taxes of $2.6 million for Q3 2021, up 276.83% year-over-year from $686908.0 in Q3 2020, and up 356.26% quarter-over-quarter from -$1.0 million in Q2 2021.
Altimmune (ALT) Change in Taxes (2016 - 2021) Analysis & Trends
Altimmune (ALT) has 6 years of Change in Taxes data on file, last reported at $2.6 million in Q3 2021.
- Change in Taxes for Q3 2021 came in at $2.6 million, up 276.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY), and the FY2025 annual result was $1.4 million, changed N/A from the prior year.
- Change in Taxes grew to $2.6 million in Q3 2021 per ALT's latest filing, from -$1.0 million in the prior quarter.
- Over five years, Change in Taxes peaked at $3.4 million in Q1 2020 and troughed at -$2.9 million in Q2 2018.
- A 5-year average of $357730.5 and a median of $203008.0 in 2017 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2018 and 2020: Change in Taxes sank 662.91% in 2018, then surged 10982.67% in 2020.
- A 5-year view of Change in Taxes shows it stood at $1.3 million in 2017, then slumped by 118.79% to -$237442.0 in 2018, then slumped by 42.98% to -$339501.0 in 2019, then surged by 562.13% to $1.6 million in 2020, then surged by 64.98% to $2.6 million in 2021.
- Business Quant data shows ALT's Change in Taxes at $2.6 million in Q3 2021, -$1.0 million in Q2 2021, and $135274.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2.59 Mn |
| Sep 30, 2021 | 2.59 Mn |
| Jun 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | -1.01 Mn |
| Mar 31, 2021 | 135,274.00 |
| Mar 31, 2021 | 135,274.00 |
| Dec 31, 2020 | 1.57 Mn |
| Dec 31, 2020 | 1.57 Mn |
| Sep 30, 2020 | 686,908.00 |
| Sep 30, 2020 | 686,908.00 |
| Jun 30, 2020 | 1.52 Mn |
| Jun 30, 2020 | 1.52 Mn |
| Mar 31, 2020 | 3.36 Mn |
| Mar 31, 2020 | 3.36 Mn |
| Dec 31, 2019 | -339,501.00 |
| Dec 31, 2019 | -339,501.00 |
| Sep 30, 2019 | -111,962.00 |
| Sep 30, 2019 | -111,962.00 |
| Jun 30, 2019 | 13,690.00 |
| Jun 30, 2019 | 13,690.00 |